Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Imetelstat sodium by Geron for Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF): Likelihood of Approval
Imetelstat sodium is under clinical development by Geron and currently in Phase III for Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF). According...
Imetelstat sodium by Geron for Myelofibrosis: Likelihood of Approval
Imetelstat sodium is under clinical development by Geron and currently in Phase I for Myelofibrosis. According to GlobalData, Phase I...
Imetelstat sodium by Geron for Post-Polycythemia Vera Myelofibrosis (PPV-MF): Likelihood of Approval
Imetelstat sodium is under clinical development by Geron and currently in Phase III for Post-Polycythemia Vera Myelofibrosis (PPV-MF). According to...
Imetelstat sodium by Geron for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
Imetelstat sodium is under clinical development by Geron and currently in Phase II for Relapsed Acute Myeloid Leukemia. According to...
Imetelstat sodium by Geron for Refractory Acute Myeloid Leukemia: Likelihood of Approval
Imetelstat sodium is under clinical development by Geron and currently in Phase II for Refractory Acute Myeloid Leukemia. According to...